Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS

Author： Alcalá-Barraza Sandra R.   Lee Michael S.   Hanson Leah R.   McDonald Abby A.   Frey William H.   McLoon Linda K.  

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.18, Iss.3, 2010-04, pp. : 179-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anatomical and Histological Factors Affecting Intranasal Drug and Vaccine Delivery

By  

Current Drug Delivery, Vol. 9, Iss. 6, 2012-11 ,pp. : 566-582

Bentham Science Publishers

Access to resources Recommend Favorite

Delivery of Neurotrophic Factors to the Central Nervous System: Pharmacokinetic Considerations

By Thorne R.G.  

Clinical Pharmacokinetics, Vol. 40, Iss. 12, 2001-01 ,pp. : 907-946

Adis International

Access to resources Recommend Favorite

Strategies for the Delivery of Leptin to the CNS

By Banks William A.   LeBel Carl P.  

Journal of Drug Targeting, Vol. 10, Iss. 4, 2002-01 ,pp. : 297-308

Informa Healthcare

Access to resources Recommend Favorite

Intranasal Drug Delivery for Brain Targeting

By  

Current Drug Delivery, Vol. 2, Iss. 2, 2005-01 ,pp. : 165-175

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Drug Delivery Systems for Releasing Growth Factors to the CNS: Focus on Alzheimer’s and Parkinson’s Diseases

By  

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 7, 2014-06 ,pp. : 557-566

Bentham Science Publishers

Access to resources Recommend Favorite